Results · Apr-Jun 2026 · filed 12 Aug 2026
Archit Organosys Q1 FY27 results
Sales grew 12% to ₹37.1 crore from ₹33.2 crore in Apr-Jun 2025.
Operating profit fell 19% to ₹3.4 crore, an operating margin of 9.1% (down 3.4 points from a year ago).
Net profit fell 29% to ₹1.4 crore from ₹2 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales +2%, net profit −28%.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 37.1 | 33.2 | +12% |
| Operating profit (EBITDA) | 3.4 | 4.1 | −19% |
| Operating margin | 9.1% | 12.5% | −3.4 pts |
| Net profit | 1.4 | 2.0 | −29% |
Standalone figures. Margins & ratios change in percentage points (pts).
The last 7 quarters
Filings that week
- 13 Aug 2026Announcement under Regulation 30 (LODR)-Newspaper Publication
- 12 Aug 2026Approval Of Unaudited Financial Result For The Quarter Ended 30Th June, 2026
- 12 Aug 2026Board Meeting Outcome for Approval Of Unaudited Financial Result For The Quarter Ended 30Th June, 2026
From the company's results filed on BSE (Standalone). Business numbers only. Education & analysis, not investment advice or a recommendation.